OACCW
Oaktree Acquisition Corp. III Life SciencesNASDAQFinancial Services$0.75+0.00%ClosedMarket Cap: $18.5M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
2.53
PEG
—
P/B
0.07
P/S
0.00
EV/EBITDA
-22.82
DCF Value
—
FCF Yield
-1.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
4.8%
ROA
3.4%
ROIC
-0.4%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $0.00 | $2.2M | $0.07 |
| FY 2025 | $0.00 | $7.3M | $0.30 |
| Q3 2025 | $0.00 | $2.0M | $0.08 |
| Q2 2025 | $0.00 | $1.9M | $0.08 |
Company Info
Sector
Financial Services
Industry
—
Country
US
Exchange
NASDAQ
Beta
0.62
Oaktree Acquisition Corp. III Life Sciences does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe. The company was incorporated in 2024 and is based in Los Angeles, California.